Hatch Medical
Hatch Medical is a privately held medical device incubator and technology brokerage firm assisting physician inventors and early-stage companies in commercializing minimally invasive peripheral, cardiovascular, and oncological devices through equity-based incubation, asset sale brokerage, and consulting services.
- Company typePrivate
- Founded2000
- HeadquartersSanta Rosa Beach, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Hatch Medical does
Hatch Medical, L.L.C. is a privately held medical device incubator and technology brokerage firm founded in 2000 by Paul Gianneschi and headquartered in Santa Rosa Beach, Florida. The firm operates a three-part platform serving physician inventors, medical device entrepreneurs, early-stage companies, and PE/VC acquirers in the minimally invasive device space, with an explicit therapeutic focus on peripheral, cardiovascular, and oncological disease states. Its device incubator provides project leadership, engineering, regulatory submission support, bench and clinical research coordination, and manufacturing oversight via ISO-certified partner networks in exchange for equity in physician-conceived projects—a risk-sharing model that allows the firm to advance technologies larger device companies might decline. Its technology brokerage arm functions like a boutique investment bank, intermediating the sale, licensing, or distribution of medical device assets, while its consulting arm delivers due diligence, valuation modeling, fairness opinions, market assessment, and distribution planning.
The firm's product portfolio spans both actively incubated technologies and previously brokered or divested assets. Current incubator/active products include the EN Snare® foreign body retrieval system (self-sizing device with three interlaced nitinol loops with platinum strands for fluoroscopic visualization), Fibrex® catheter patency device (tri-axial delivery with shaped-memory helical nitinol stripping coil for fibrin removal from central venous catheters), PortIO™ implantable intraosseous vascular access device (first subcutaneous long-term IO access without a reservoir), AdVENTage® bone marrow aspiration biopsy system (patented venting mechanism to reduce negative pressure), VascuTech Medical radial sheath line (4F–7F with proprietary Oculus™ hemostatic valve and Vapor™ transition-less thin-wall extrusion), and Scorpion® liver access systems. Divested or licensed assets include Clik-FIX catheter securement devices (sold to B. Braun Medical, 2022), EN Snare® (sold to Merit Medical Systems for $21 million, 2009), DriPAD™ liquid solidification technology (sold to Merit Medical), FlatCath™ low-profile hemodialysis catheter (licensed to InterV Medical), Novatek AAA stent-graft IP (sold to Endologix), Phase One Medical anchoring technology (sold to NDC), and B. Braun peripheral/carotid stent and embolic protection assets (brokered to Scion Medical).
Hatch Medical monetizes through a hybrid of one-time transaction/brokerage fees on asset sales and licensing deals, ongoing royalty streams from licensed technologies, equity participation in incubated projects that pays out on sale, license, or commercialization milestones, and professional services fees for due diligence, valuation, and consulting engagements. Pricing is quote-based and individually negotiated with no publicly disclosed fee schedules. The firm operates with a lean 1–10 employee base anchored by two principals (Gianneschi and Steven M. Hvozda, both C.R. Bard alumni), supplemented by a six-member Physician Advisory Council and an extended network of university teaching hospitals and ISO-certified manufacturing partners for catheter extrusion, nitinol wire forming, and injection molding. Recent strategic activity includes a 2024 joint venture with PAVmed/PMX for PortIO commercialization, brokered mandates for EndoBar Solutions, ADN International, and Fixit Medical, and ongoing co-development partnerships with Syncro Medical Innovations (2021) and VascuTech Medical (2020).
Hatch Medical firmographics
Firmographics- Name
- Hatch Medical
- Legal name
- Hatch Medical, L.L.C.
- Website
- https://hatchmedical.com
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Hatch Medical is a privately held medical device incubator and technology brokerage firm assisting physician inventors and early-stage companies in commercializing minimally invasive peripheral, cardiovascular, and oncological devices through equity-based incubation, asset sale brokerage, and consulting services.
- Ownership category
- akta.pro rank
Where Hatch Medical is headquartered
LocationHeadquarters
- HQ city
- Santa Rosa Beach
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Hatch Medical business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain
Revenue model
- Device Incubation Services: Hatch Medical provides project leadership, industry expertise and resources to physician inventors in exchange for equity in physician-conceived projects. This risk-sharing model enables the company to take on projects that larger companies might reject without upfront costs or out-of-pocket expenses for inventors.
- Technology Brokerage: Operating as a boutique investment bank, Hatch Medical assists clients with the sale, license or distribution of medical device assets. Revenue generated through successful transactions in the form of brokerage fees, success fees, or ongoing royalties from licensed technologies.
- Consulting Services: Due diligence on prospective acquisition targets, target market assessment, focus groups, physician interviews, clinical product evaluations, business plan review, valuation modeling, and distribution planning. Revenue through professional services fees.
- Engineering and Regulatory Support: Product engineering and design, bench top testing, regulatory submissions, clinical research, and manufacturing coordination through ISO certified partners.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Hatch Medical product offering
Product offeringCore offering
Hatch Medical is a medical device incubator and technology brokerage firm that assists physician inventors, entrepreneurs, and early-stage companies with the commercialization of minimally invasive medical device technologies. The company provides three core services: (1) Device Incubator Services, offering project leadership and resources in exchange for equity through a risk-sharing model; (2) Technology Brokerage, operating as a boutique investment bank to facilitate the sale, license, or distribution of medical device assets; and (3) Consulting Services, providing due diligence, valuation, and distribution planning. Its focus areas are peripheral, cardiovascular, and oncological disease states.
Product overview
Hatch Medical is a medical device incubator and technology brokerage firm that operates as a three-part platform: (1) Device Incubator Services that assist physician inventors with product development in exchange for equity through a risk-sharing model; (2) Technology Brokerage that facilitates sale, license, or distribution of medical device assets similar to a boutique investment bank; and (3) Consulting Services covering due diligence, valuation, and distribution planning. The company's product portfolio includes developed and brokered devices such as the EN Snare® foreign body retrieval system, Fibrex® catheter patency device, PortIO™ implantable intraosseous vascular access device, AdVENTage® bone marrow biopsy system, VascuTech radial sheath products, and Scorpion® liver access systems. Additional brokered technologies include ShortCut™ GJ feeding tubes, Thermotex heat therapy systems, Clik-FIX® catheter securement devices, DriPAD™ liquid solidification technology, and FlatCath™ hemodialysis catheters. The company specializes in minimally invasive devices for peripheral, cardiovascular, and oncological disease states.
Differentiator
Problem solved
Functional benefit
Products and services
- Device Incubator Services
- Technology Brokerage
- Consulting Services
- EN Snare Retrieval and Foreign Body Removal System
- Fibrex Catheter Patency Device
- PortIO Implantable Intraosseous Vascular Access Device
- AdVENTage Bone Marrow Aspiration Biopsy System
- VascuTech Medical Radial Sheath Line
- ShortCut GJ Feeding Tube
- Thermotex Far Infrared Heat Therapy Systems
- Scorpion Liver Access Systems
- Clik-FIX Catheter Securement Devices
- DriPAD Technology
- FlatCath Low Profile Hemodialysis Catheter
- SideStep Side Loading Steering Handle
- MorCor Biopsy System
Quantifiable outcome
- EN Snare sold to Merit Medical Systems for $21 million in 2009
- +2 more outcomes
Companies that use Hatch Medical
Customer profileNamed customers10 records
Segments5 records
Ideal customer profiles4 records
Hatch Medical technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Hatch Medical partnerships and signals
Strategic signalPartnerships
19 partnerships are on record, tiered core, major and minor.
- PAVmedcorePAVmed (Nasdaq: PAVM) and Hatch Medical entered into a joint venture agreement to complete technology development and commercialization of the PortIO Implantable Intraosseous Vascular Access Device.
- B. Braun Medical Inc.majorSuccessfully brokered asset sale of Starboard Medical's Clik-FIX Catheter Securement Product Line to B. Braun Medical, Inc.
- Syncro Medical InnovationsmajorHatch Medical and Syncro Medical Innovations partnered to commercialize the advanced Gabriel Feeding Tube technology.
- VascuTech MedicalmajorHatch Medical and VascuTech Medical partnered to commercialize advanced Radial Sheath and Micro-Introducer lines developed with Dr. Jonathan Levine.
- Argon Medical DevicesmajorHatch Medical signed manufacturing and distribution pact with Argon Medical Devices for Scorpion Liver Access Systems and other technologies.
- Merit Medical Systems, Inc.majorHatch Medical sold EN Snare assets to Merit Medical Systems for $21 million. Also acquired Quellent's DriPAD technology.
- Scion Medical Technologies, Inc.majorHB Technologies core-tissue biopsy instrument asset sale to Scion Medical. B. Braun Medical's peripheral and carotid stents assets also sold to Scion Medical.
- Nitinol Devices & Components (NDC)majorPhase One Medical's Optional Vena Cava Filter Platform asset sale to NDC (formerly a J&J company).
- InterV MedicalmajorFlatCath Low profile Hemodialysis Catheter licensed manufacturing and distribution to InterV Medical.
- Endologix, Inc.majorNovatek AAA Stent-graft Patent Portfolio intellectual property sale to Endologix, Inc.
- EndoBar SolutionsminorHatch Medical retained by EndoBar Solutions to sell Embolotherapy System, Lamina.
- ADN InternationalminorHatch Medical retained by ADN International to secure commercialization partner for Strome-Blitzer Cytologic Collection Balloon.
- Fixit MedicalminorHatch Medical retained by Fixit Medical to broker Novel Drainage Catheter Fixation Technology.
- Medical Device Technologies (MD TECH)majorHatch Medical joint venture signed global pact with Medical Device Technologies for manufacturing and distribution.
- Welsh, Flaxman and Gitler, LLCminorIntellectual property attorneys providing patent research and trademark services.
- Physician Advisory CouncilcoreSix-member panel of world-renowned physicians including interventional radiologists, vascular surgeons, and interventional cardiologists assisting in evaluation of new product opportunities.
- ISO Certified Medical Device Manufacturing FirmscoreNetwork of independent affiliates including manufacturing partners for injection molding, catheter extrusion, and nitinol wire formation.
- University Teaching HospitalsminorClinical research partners providing feasibility testing and product performance assessment.
- Yale UniversityminorHatch Medical licensed sharps safety technology from Yale University in July 2001.
Scale indicators4 records
Recent moves8 records
Expansion highlights5 records
Hatch Medical competitors and assessment
Company assessmentDirect peers
- The Foundry: The Foundry is a medical device incubator that develops minimally invasive technologies from physician-conceived concepts, structuring joint ventures and licensing arrangements similar to Hatch Medical's incubator model.
- Synecor: Synecor is a medical device incubator focused on developing and commercializing novel interventional and minimally invasive devices, comparable to Hatch Medical's physician-inventor incubation and equity-for-services model.
- ExploraMed: ExploraMed is a medical device incubator founded by serial entrepreneur Mir Imran that incubates physician-conceived minimally invasive devices, sharing equity, expertise, and development resources in a structurally identical model to Hatch Medical.
- BioEnterprise: BioEnterprise was a medical technology business accelerator that supported commercialization of health IT, medical device, and biotech ventures, paralleling Hatch Medical's physician-inventor incubation and commercialization support services.
- Confluent Medical Technologies: Confluent Medical Technologies is a medical device contract developer and manufacturer (CDMO) specializing in nitinol-based interventional devices, offering product development through manufacturing services analogous to Hatch's engineering and manufacturing coordination through ISO-certified partners.
Broad incumbents
- Freudenberg Medical (formerly Vention Medical): Freudenberg Medical is a global medical device CDMO with broad device development and manufacturing capabilities including nitinol and catheter specialties, competing for development and production work that Hatch Medical coordinates among partner manufacturers.
Others
- B. Braun Medical: B. Braun Medical is a recurring acquirer of Hatch-brokered technologies (notably Clik-FIX catheter securement devices and peripheral/carotid stent assets) and a key counterparty in Hatch's brokerage transaction flow.
- Merit Medical Systems: Merit Medical Systems is a strategic acquirer in interventional and peripheral vascular devices and a counterparty in Hatch's largest disclosed transaction (EN Snare asset purchase for $21 million in 2009 and DriPAD acquisition).
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Hatch Medical social profiles
Digital presenceHatch Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Hatch Medical leadership team
Management profileNumber of profiles
Profiles2 records
Hatch Medical funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Hatch Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Hatch Medical
What does Hatch Medical do?
Hatch Medical is a medical device incubator and technology brokerage firm that assists physician inventors, entrepreneurs, and early-stage companies with the commercialization of minimally invasive medical device technologies. The company provides three core services: (1) Device Incubator Services, offering project leadership and resources in exchange for equity through a risk-sharing model; (2) Technology Brokerage, operating as a boutique investment bank to facilitate the sale, license, or distribution of medical device assets; and (3) Consulting Services, providing due diligence, valuation, and distribution planning. Its focus areas are peripheral, cardiovascular, and oncological disease states.
Is Hatch Medical a public or private company?
Hatch Medical is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Hatch Medical founded?
Hatch Medical was founded in 2000. It employs 1 to 10 people.
Where is Hatch Medical based?
Hatch Medical is headquartered in Santa Rosa Beach, United States, in the North America region.
How does Hatch Medical make money?
Four revenue lines are on record. Device Incubation Services are the primary driver. The others are technology Brokerage, consulting Services and engineering and Regulatory Support.
Who are Hatch Medical's main competitors?
Direct peers on record are The Foundry, Synecor, ExploraMed, BioEnterprise and Confluent Medical Technologies. Freudenberg Medical (formerly Vention Medical) is listed as a broad incumbent. Others are B. Braun Medical and Merit Medical Systems.
Does Hatch Medical have an API?
No public API is recorded for Hatch Medical.